TherapeuticsMD, Inc. earnings per share and revenue
On 12 nov. 2025, TXMD reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analystes forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were TherapeuticsMD, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, TherapeuticsMD, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to TherapeuticsMD, Inc.'s Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is TherapeuticsMD, Inc. expected to report next?
The next earning report is scheduled for 25 mars 2026.
What are the forecasts for TherapeuticsMD, Inc.'s next earnings report?
Based on --
analystes, TherapeuticsMD, Inc. is expected to report EPS of -- and revenue of -- for Q4 2025.